Literature DB >> 3486912

B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.

A Muraguchi, H Nishimoto, N Kawamura, A Hori, T Kishimoto.   

Abstract

This paper demonstrates that B cell lines, as well as normal activated B cells generate and respond to B cell-specific growth factor(s) (BCGF). BCGF derived from B cells (B-BCGF) appears to be distinct from interleukin 1, interleukin 2 (IL 2), B cell stimulatory factor, BCGF-II, interferon-gamma, or transforming growth factor. It acts on activated B cells, but not on resting G0 phase B cells to induce proliferation. B cell lines, immortalized by Epstein-Barr virus, constitutively secrete 10-fold higher level of B-BCGF compared with normal activated B cells, suggesting that an activated autocrine loop might be operating in immortalized B cells. On the basis of our observations, we postulate that B cell clonal expansion may occur, at least in part, through a B-BCGF-dependent autocrine pathway similar to IL 2 effect on T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Activity of soluble factors produced by Epstein-Barr virus-transformed human B lymphocytes on different cell lines.

Authors:  C Garzelli; A Bazzichi
Journal:  Experientia       Date:  1991-07-15

2.  NDA3: a differentiation antigen associated with the receptor for B cell growth factor.

Authors:  N Suciu-Foca; C Rohowsky-Kochan; S J Rosochacki; E Cristea; J D Cai; E Reed; D W King
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 3.  Rheumatology practice in Japan: challenges and opportunities.

Authors:  Kenji Oku; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2019-03-19       Impact factor: 2.631

4.  Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA.

Authors:  M C Kinney; R D Collins; J Whitlock; J B Cousar; L B Vogler
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Modulation of the response to B-cell growth factor (BCGF) of hairy cells from a patient under IFN-alpha therapy.

Authors:  E Génot; C Mathiot; J P Kolb
Journal:  Blut       Date:  1987-07

Review 6.  B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

Authors:  T Kishimoto
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

7.  Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.

Authors:  Y L Lau; J G Shields; R J Levinsky; R E Callard
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

8.  The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).

Authors:  R E Callard; Y L Lau; J G Shields; S H Smith; J Cairns; L Flores-Romo; J Gordon
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

9.  Inhibitory mechanism of the proliferative responses of resting B cells: feedback regulation by a lymphokine (suppressive B-cell factor) produced by Fc receptor-stimulated B cells.

Authors:  T Ohno; M Miyama-Inaba; T Masuda; K Fukuma; K Ajisaka; R Suzuki; K Kumagai; T Kanoh; H Uchino
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

10.  Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth.

Authors:  G R Guy; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.